What is Orthogonal Thinker?
Orthogonal Thinker operates as an innovative biotech holding company, strategically acquiring and accelerating businesses focused on psilocybin, psychoactive compounds, plant sciences, and the broader mental wellness landscape. By integrating AI and Blockchain technologies, the company aims to elevate and empower humanity through plant medicine, setting a new standard for health and mental wellness solutions. This approach positions Orthogonal Thinker at the forefront of a rapidly evolving industry, leveraging cutting-edge technology to unlock the therapeutic potential of novel compounds.
How much funding has Orthogonal Thinker raised?
Orthogonal Thinker has raised a total of $6M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2020): $6M with participation from Republic Labs and Pay It Forward
Key Investors in Orthogonal Thinker
Republic Labs
Republic Labs is a venture capital firm known for its involvement in innovative and emerging market sectors, likely providing strategic capital and guidance to companies like Orthogonal Thinker.
Pay It Forward
An undisclosed investor participating in the funding round, potentially focused on impact investing or early-stage ventures within the health and wellness space.
What's next for Orthogonal Thinker?
The recent major strategic investment signifies a critical growth phase for Orthogonal Thinker, likely enabling further expansion of its portfolio companies and acceleration of research and development initiatives. With a focus on integrating advanced technologies like AI and Blockchain, the company is poised to innovate within the mental wellness and plant medicine sectors. This capital infusion is expected to fuel strategic acquisitions and partnerships, solidifying Orthogonal Thinker's position as a leader in developing next-generation therapeutic solutions.
See full Orthogonal Thinker company page
